Centre for Pain IMPACT

RESEARCH CENTRE

INVESTIGATING MECHANISMS OF PAIN TO ADVANCE CLINICAL TRANSLATION

The Centre for Pain IMPACT, directed by A/Prof James McAuleyA/Prof Sylvia Gustin, Dr Siobhan Schabrun and A/Prof David Seminowicz conducts research that encompasses basic science through to clinical and translational research.

Our research investigates the causes of chronic pain; develops and tests the efficacy and effectiveness of new treatment approaches; and implements new treatment approaches into clinical practice.

The research covers a range of conditions: low back pain, osteoarthritis, temporomandibular disorder, focal hand dystonia, headache, complex regional pain syndrome, migraine, burning mouth syndrome, sickle cell disease, fibromyalgia, rheumatoid arthritis, spinal cord injury neuropathic pain, trigeminal neuropathic pain and trigeminal neuralgia.

Our team uses different research methods, including: animal (rodent) models, human models, neuroimaging, experimental methods (non-invasive brain stimulation, quantitative sensory testing), cohort studies, randomised controlled trials, implementation trials, and qualitative research.

The Centre also provides ongoing pain-related educational activities, including media, public lectures, clinical workshops, and seminars.

The overarching aims of the Centre for IMPACT are to:

  • profile NeuRA’s world class pain research
  • facilitate collaboration within and beyond NeuRA
  • raise awareness of NeuRA’s pain activities by providing:
    • a platform for research participant recruitment
    • a forum for public and clinician education.
    • leverage expertise within NeuRA to seek external funding support (e.g. NHMRC CRE, industry, philanthropy).

LATEST NEWS AND EVENTS

The 17th International Forum for Back and Neck Pain Research in Primary care

The members of the local organising committee are pleased to announce that the 17th International Forum for Back and Neck Pain Research in Primary Care will be held 11th to 13th November 2021. For the first time, the Forum will be a global virtual conference. The program will run 8am to 1:30pm in three time zones (Eastern Standard Time, Central European Time and Australian Eastern Daylight Saving Time). These three time zones will allow us to cater to our colleagues in North and South America, Europe and Africa, and Asia, Australasia and Pacific.

 

The theme of Forum XVII, ‘Global’, refers to the global challenge of back and neck pain. Delegates are encouraged to explore new, original ideas that bring researchers, clinicians, policy makers and consumers from around the world together to reduce the global burden of back and neck pain.


Registration

Registration allows a delegate to attend all sessions in all three time zones.

Type Cost Registration link
Early-bird registration $A330 GST inc Register here until September 30
Standard registration $A440

 

If you have an annual gross income of less than $US10,000 you are eligible for a 50% discount on registration. To support delegates from low-income countries to attend the Forum we have reserved twenty free registrations. These will be restricted to people who have an annual gross income of less than $US5,000. Please contact Dr Saurab Sharma for application details (email:saurabsharma1@gmail.com).


Submit an abstract

Submission of an abstract acknowledges your acceptance for the abstract to be used at the 17th International Forum for Back and Neck Pain Research in Primary Care. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract. Please follow the link here to submit an abstract.

CENTRE FOR PAIN IMPACT TEAM

YANNICK GILANYI Research Associate : y.gilanyi@neura.edu.au

BRISHNA SHAH Research Associate : b.shah@neura.edu.au

JACK DEVONSHIRE Honours Student : j.devonshire@neura.edu.au

HARRISON HANSFORD Honours Student : h.hansford@neura.edu.au

THIAGO FOLLY Research Assistant

ANIKA HAIGH Research Assistant : a.haigh@neura.edu.au

PAULINE ZAHARA Research Assistant

DR IAN SKINNER Postdoctoral Research Fellow

NELL NORMAN-NOTT PhD Student

BROOKE NAYLOR Masters Student, Clinical Psychology

DANIEL HULTBERG Medical Student

ANTON PAULSON Medical Student

DAVID KANG Medical Student

LUKE JENKINS PhD Student

REBECCA LIVINGS PhD Student

WEI-JU CHANG Postdoctoral Fellow

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

LEAD!- Leveraging Evidence into Action on Dementia

Currently, there is no effective treatment for dementia, highlighting the urgent need to preventing more cases through evidence-based strategies for risk reduction. As there is an overlap between the risk factors for dementia and other preventable non-communicable diseases including stroke, diabetes, and heart disease, it is important to build upon proven risk-reduction strategies. What is LEAD? LEAD! is a project funded by the NHMRC Boosting Dementia Research Grant led by Professor Kaarin Anstey. It involves an international collaboration between leading academics, clinicians, consumers, and community members. Organisations involved include the Department of Health, WHO, Dementia Australia, Alzheimer’s Disease International, Diabetes Australia, and Heart Foundation. The project aims to translate dementia research and implement evidence-based strategies for dementia risk reduction to individuals, communities, and healthcare centres. Three workstreams The project has three concurrent workstreams over five years: Development, Implementation, and Evaluation and adoption. The Development stream, led by Professor Kaarin Anstey and Associate Professor Peters, focuses on building a new tool for predicting dementia and other non-communicable diseases including stroke, diabetes or myocardial infarction. The tool will be available to the public, researchers and clinicians. It will save clinical assessment time, accurately predict multiple outcomes and will be more acceptable in comparison to using individual tools for each disease outcome. The Implementation stream led by Professor Nicola Lautenschalger’s team at the University of Melbourne, will develop strategies to support the implementation of dementia risk reduction evidence by engaging with consumers, clinicians, policy makers, and the public. The stream will develop strategies for incorporating the new risk assessment tool into various technological platforms (e.g., websites or apps). The Evaluation and adoption stream, led by Professor Anstey and in collaboration with Professor Louisa Jorm and Dr Heidi Welberry at UNSW, focuses on measuring trajectories of Australian’s national risk factor profiles for multiple chronic diseases. Collaboration with key stakeholders including the WHO will help build an evaluation framework and methodology for implementing evidence on dementia risk reduction based on WHO guidelines at national level and in the global context.
PROJECT